Whanin Pharmaceutical Company Limited (016580) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Whanin Pharmaceutical Company Limited Company Snapshot

Business Description:

Whanin Pharmaceutical Company Limited operates in the Medicinals and botanicals sector. Whan In Pharm Co.,Ltd. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company's offerings consist of antipsychotics, alcoholism treatments, antibiotics, antidepressants, antiepileptics, antiinflammatory analgesics, anxiolytics, hypnotics, cardiovascular drugs, gastrointestinal drugs, respiratory drugs, dermatologic drugs, antiparkinson drugs, nootropics, immunostimulating agents, multi-vitamins, osteoporosis treatments and antifungal agents. In our complete report available for purchase the company is compared to: Myungmoon Pharmaceutical Company Limited, Hanall Biopharma Company Limited and Samil Pharmaceutical Co., Ltd..

Whanin Pharmaceutical Company Limited

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 6,230.00
(Figures in Korean Won)

1 Week	1.6%	13 Weeks	7.4%

4 Weeks	2.0%	52 Weeks	-9.4%

Whanin Pharmaceutical Company Limited Key Data:

Ticker:	016580	Country:	KOREA (SOUTH)

Exchanges:	SEO	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	105,687,139,000 (Year Ending Jan 2011).	Employees:	393

Currency:	Korean Won	Market Cap:	95,113,846,100

Fiscal Yr Ends:	December	Shares Outstanding:	15,267,070

Share Type:	Common	Closely Held Shares:	767,210

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.